Randomised phase III study of S-1 alone versus S-1 plus lentinan for unresectable or recurrent gastric cancer (JFMC36-0701).
Yoshino S, Nishikawa K, Morita S, Takahashi T, Sakata K, Nagao J, Nemoto H, Murakami N, Matsuda T, Hasegawa H, Shimizu R, Yoshikawa T, Osanai H, Imano M, Naitoh H, Tanaka A, Tajiri T, Gochi A, Suzuki M, Sakamoto J, Saji S, Oka M.
Yoshino S, et al. Among authors: nemoto h.
Eur J Cancer. 2016 Sep;65:164-71. doi: 10.1016/j.ejca.2016.06.012. Epub 2016 Aug 5.
Eur J Cancer. 2016.
PMID: 27501505
Free article.
Clinical Trial.